Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ALHCNASDAQ:CRNXNYSE:HNGRNASDAQ:IMAC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALHCAlignment Healthcare$14.40-1.2%$16.01$7.05▼$21.06$2.85B1.222.06 million shs2.21 million shsCRNXCrinetics Pharmaceuticals$30.50-1.1%$31.42$24.10▼$62.53$2.86B0.28845,032 shs480,466 shsHNGRHanger$18.72$18.70$13.42▼$22.67$732.38M1.28356,429 shsN/AIMACIMAC$0.05+3.7%$0.04$0.75▼$1.65$1.20M-0.88708,132 shs18,140 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALHCAlignment Healthcare0.00%-4.51%-8.16%-18.23%+90.73%CRNXCrinetics Pharmaceuticals0.00%-5.19%-2.77%-11.39%-31.14%HNGRHanger0.00%0.00%0.00%0.00%0.00%IMACIMAC+3.65%+10.73%+24.90%-89.20%-97.99%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALHCAlignment Healthcare1.4401 of 5 stars2.32.00.00.01.82.50.6CRNXCrinetics Pharmaceuticals3.2553 of 5 stars3.50.00.03.71.52.50.0HNGRHangerN/AN/AN/AN/AN/AN/AN/AN/AIMACIMACN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALHCAlignment Healthcare 2.64Moderate Buy$17.1719.21% UpsideCRNXCrinetics Pharmaceuticals 2.91Moderate Buy$74.56144.44% UpsideHNGRHanger 0.00N/AN/AN/AIMACIMAC 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HNGR, IMAC, CRNX, and ALHC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025ALHCAlignment HealthcareStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/2/2025ALHCAlignment HealthcareUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$16.00 ➝ $17.004/15/2025ALHCAlignment HealthcareRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$17.00 ➝ $22.004/8/2025ALHCAlignment HealthcareStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $23.003/25/2025CRNXCrinetics PharmaceuticalsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$60.00(Data available from 6/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALHCAlignment Healthcare$2.70B1.05N/AN/A$0.53 per share27.17CRNXCrinetics Pharmaceuticals$1.04M2,745.88N/AN/A$14.29 per share2.13HNGRHanger$1.12B0.65$1.88 per share9.98$2.85 per share6.57IMACIMAC$15.22M0.08N/AN/A$0.69 per share0.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALHCAlignment Healthcare-$128.04M-$0.48N/AN/AN/A-3.02%-80.49%-11.75%7/30/2025 (Estimated)CRNXCrinetics Pharmaceuticals-$298.41M-$3.82N/AN/AN/AN/A-30.95%-28.12%8/6/2025 (Estimated)HNGRHanger$41.98M$0.9519.7115.60N/A3.17%35.72%4.00%N/AIMACIMAC-$10.54MN/A0.00N/AN/A-75.40%-52.17%-34.51%N/ALatest HNGR, IMAC, CRNX, and ALHC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025CRNXCrinetics Pharmaceuticals-$0.99-$1.04-$0.05-$1.04$0.10 million$0.36 million5/1/2025Q1 2025ALHCAlignment Healthcare-$0.12-$0.05+$0.07-$0.05$889.83 million$926.93 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALHCAlignment HealthcareN/AN/AN/AN/AN/ACRNXCrinetics PharmaceuticalsN/AN/AN/AN/AN/AHNGRHangerN/AN/AN/AN/AN/AIMACIMACN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALHCAlignment Healthcare2.951.691.69CRNXCrinetics PharmaceuticalsN/A22.5322.53HNGRHanger3.711.230.85IMACIMAC0.011.271.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALHCAlignment Healthcare86.19%CRNXCrinetics Pharmaceuticals98.51%HNGRHanger79.17%IMACIMAC24.27%Insider OwnershipCompanyInsider OwnershipALHCAlignment Healthcare7.00%CRNXCrinetics Pharmaceuticals4.60%HNGRHanger4.36%IMACIMAC10.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALHCAlignment Healthcare1,679197.84 million183.99 millionOptionableCRNXCrinetics Pharmaceuticals21093.63 million89.32 millionOptionableHNGRHanger5,20039.12 million37.42 millionOptionableIMACIMAC10626.49 million23.84 millionNot OptionableHNGR, IMAC, CRNX, and ALHC HeadlinesRecent News About These CompaniesYou’ll Love This iMac-Inspired Apple Watch Charger StandJune 19 at 6:22 AM | msn.comIMAC Holdings Issues Promissory Note for $301,000June 18 at 5:46 PM | tipranks.comRecreate the classic iMac G3 era with this cute Apple Watch chargerJune 18 at 2:14 AM | msn.comHide my wallet – this Apple Watch charger looks like the best iMac ever and has one neat design touchJune 18 at 2:14 AM | msn.comSpigen's iMac G3-Inspired Apple Watch Charger Is the Nostalgic Accessory You Didn't Know You NeededJune 17 at 7:34 AM | techtimes.comSpigen just released the Apple Watch charger stand I’ve always wantedJune 17 at 2:32 AM | 9to5mac.comWhat’s next for Mac? Here’s what I predict is coming to the Mac line-upJune 13, 2025 | msn.comApple just supercharged MacBook & iMac: Liquid Glass macOS 26 Tahoe revealed at WWDC 2025; check details hereJune 10, 2025 | fortuneindia.comIMAC Holdings Appoints New Board Members for Strategic GrowthJune 6, 2025 | tipranks.comHistory of the eMacJune 6, 2025 | msn.comIMAC Holdings Issues Promissory Note for $455,000June 5, 2025 | tipranks.comGet the Apple 2024 iMac 24-inch (M4, 10-core CPU/10-core GPU, 16GB/256GB, Green) for $1,297.06 (originally $1,499.00) – $201.94 savingsJune 4, 2025 | msn.comApple's Upcoming macOS 26 Could Be Bad News For Owners Of Older ModelsJune 4, 2025 | msn.comIt’s time for Apple to re-introduce this long discontinued macOS featureJune 2, 2025 | 9to5mac.commacOS 26 may not support these four Mac models: Is yours on the list?May 30, 2025 | msn.comWhen are new Macs coming? Here’s the latestMay 29, 2025 | 9to5mac.comRumor: macOS 26 may not support some more recent Macs including MacBook Air 2020 with Intel CPUMay 29, 2025 | tweaktown.commacOS 26 may drop support to these Intel Macs as Apple winds down transitionMay 29, 2025 | bgr.comThis Year’s ‘macOS 26’ Release May End Support for These MacsMay 29, 2025 | idropnews.comApple is reportedly dropping support for nearly every Intel Mac this yearMay 29, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHNGR, IMAC, CRNX, and ALHC Company DescriptionsAlignment Healthcare NASDAQ:ALHC$14.40 -0.17 (-1.17%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$14.41 +0.01 (+0.07%) As of 06/18/2025 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.Crinetics Pharmaceuticals NASDAQ:CRNX$30.50 -0.35 (-1.13%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$30.51 +0.01 (+0.03%) As of 06/18/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. It is also developing CRN04894, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and Cushing's disease. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; identified investigational orally available somatostatin receptor type 3 targeted nonpeptide agonists for the treatment of autosomal dominant polycystic kidney disease; and developing thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease, as well as Oral GLP-1 and GIP nonpeptides for the treatment of diabetes and obesity. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.Hanger NYSE:HNGRHanger, Inc. provides orthotic and prosthetic (O&P) services in the United States. It operates in two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and offers payor network contracting services to other O&P providers. The Products & Services segment engages in the distribution of various O&P parts, componentry, and devices to independent O&P providers; development of specialized rehabilitation technologies; and provision of evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of December 31, 2021, the company operated approximately 760 patient care clinics and 115 satellite locations in 47 states and the District of Columbia. It also distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.IMAC NASDAQ:IMAC$0.05 +0.00 (+3.65%) As of 06/18/2025IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
